Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
David O'Neal MD, FRACP

David N. O'Neal MD, FRACP

Professor, Department of Medicine, University of Melbourne, Victoria, Australia

David O’Neal is a clinical endocrinologist with an interest in diabetes research. He is a Professor with The University of Melbourne and a senior consultant endocrinologist with the Department of Endocrinology at St Vincent’s Public Hospital. He has a significant commitment to patient care which include inpatient and outpatient responsibilities. He heads an insulin pump clinic. He also works as a general physician at Werribee Mercy Hospital. He has established the Diabetes Technology Research Group in the clinical trials unit with the University of Melbourne Department of Medicine at St. Vincent’s Hospital His research interests include investigator initiated clinical trials involving the evaluation of new technologies in the management of patients with diabetes and their interaction with the technology. He has research collaborations with clinicians, academics, and industry both in Australia and internationally.


Dr. O'Neal reports honoraria and research support from:

  • Medtronic
  • Insulet
  • Abbott
  • Sanofi
  • Novo-Nordisk
  • Merck